TriSalus Life Sciences, Inc. TLSI Increase (Decrease) in Prepaid Expense

Increase (Decrease) in Prepaid Expense at other companies

OS TherapiesOSTX

-$63.08K—

Robinhood Markets, Inc.HOOD

$54M+315%

Dine Brands GlobalDIN

-$5.4M-92.9%

JAC

Jackson Acquisition Company IIJACS

$21.18K-39.0%

NMP

Nuveen Prem Inc Muni FundNMP

$34.85K+359%

MGP IngredientsMGPI

$3.67M+258%

Other financials

Income statement

See full

Revenue$8.9M-2.9%

Gross profit$7.7M0.0%

Operating income-$8.4M-14.8%

Net income$1.5M+115%

EPS (diluted)$0.03+108%

Balance sheet

See full

Cash & equivalents$56.6M+324%

Total debt$33.1M+4.4%

Total equity$12.8M+137%

Total assets$71.0M+148%

Cash flow

See full

Operating cash flow-$6.5M-44.0%

CapEx$141.0K-81.3%

Free cash flow-$6.6M-26.0%

Valuation

See full

Market cap$279.45M+49.6%

Enterprise value$255.97M+33.6%

P/S6.2×+1.0×

Profitability

See full

Gross margin85.1%-0.5pp

Operating margin-62.4%-16.8pp

Net margin-60.9%-13.4pp

FCF margin-45.2%-16.8pp

Returns & leverage

See full

Return on equity253.3%—

Debt / equity2.6×—

Current ratio5.8×+3.6×

Where this comes from

Reported directly by TriSalus Life Sciences, Inc. in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInPrepaidExpense.

The official record: TriSalus Life Sciences, Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about TriSalus Life Sciences, Inc.'s increase (decrease) in prepaid expense.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is TriSalus Life Sciences, Inc.'s increase (decrease) in prepaid expense?: TriSalus Life Sciences, Inc. (TLSI) reported increase (decrease) in prepaid expense of $423K in Q1 2026.
How has TriSalus Life Sciences, Inc.'s increase (decrease) in prepaid expense changed year-over-year?: TriSalus Life Sciences, Inc.'s increase (decrease) in prepaid expense increased by 182.8% year-over-year, from -$511K to $423K.